(5alpha)-17-(Cyclopropylmethyl)-6-methylene-4,5-epoxymorphinan-3,14-diol(CAS: 55096-26-9)

This compound is regulated under the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) and requires proper labeling for health and environmental hazards. Additionally, under the European Union’s REACH regulation, it must be reported if used above certain thresholds. FDA and EPA have requirements for its safe handling, storage, and disposal, mainly focusing on its potential for abuse and environmental impact.

Yes, there are alternative reagents and routes that can be used, such as using morphine or other 3,14-diol compounds as starting materials. Isomers like (6alpha)-methylene-4,5-epoxymorphinan-3,14-diol can also serve as alternatives, but they may require different synthetic strategies and conditions.

Research trends for this compound are focused on its potential as a therapeutic agent for pain management and addiction treatment. Market trends suggest increasing demand in pharmaceuticals, driven by ongoing clinical trials and regulatory approvals. However, due to its controlled status, market growth is tightly regulated and heavily scrutinized.

Waste containing this compound should be collected in properly labeled containers and stored in a secure area. Incineration or professional waste disposal services are recommended. Environmental protection measures include preventing the waste from entering water bodies and ensuring all necessary permits are obtained. Proper disposal methods are crucial to prevent environmental contamination and ensure compliance with regulatory requirements.